We provide you with 20 years of free, institutional-grade data for SNOA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SNOA. Explore the full financial landscape of SNOA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about SNOA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sonoma Pharmaceuticals, Inc(NASDAQ:SNOA) 
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobia...
Website: http://www.sonomapharma.com
Founded: 1999
Full Time Employees: 19
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic